PREDICTORS OF BUPRENORPHINE NALOXONE DOSING IN A 12 WEEK TREATMENT TRIAL FOR OPIOID DEPENDENT YOUTH: SECONDARY ANALYSES FROM A NIDA CLINICAL TRIALS NETWORK STUDY
Saved in:
CHAKRABARTI, A., ET AL., PREDICTORS OF BUPRENORPHINE NALOXONE DOSING IN A 12 WEEK TREATMENT TRIAL FOR OPIOID DEPENDENT YOUTH: SECONDARY ANALYSES FROM A NIDA CLINICAL TRIALS NETWORK STUDY. DRUG AND ALCOHOL DEPENDENCE, Vol. 107, no. 2-3 (2010), p. 253-256.
Ref.
166786
Location:
SIIS R.854 Archivo
Palabras clave:
Adolescentes, Alcohol, Buprenorfina, Cannabis, Cocaína, Dosis, Drogodependencias, Edad, Evolución, Fármacos, Género, Juventud, Nicotina, Opiáceos, Raza, Tratamiento médico, EE.UU.
Adolescentes, Alcohol, Buprenorfina, Cannabis, Cocaína, Dosis, Drogodependencias, Edad, Evolución, Fármacos, Género, Juventud, Nicotina, Opiáceos, Raza, Tratamiento médico, EE.UU.
Be the first to leave a comment!